# Varex Imaging Corp (VREX) — merger/definitive [pending]
Source: SEC API (secapi.ai) · situation sit_ba22e2f5c3d6d3cb56b4 · retrieved 2026-08-14T01:27:11.071Z

## Overview
Varex Imaging Corporation designs, manufactures, distributes and services X-ray imaging components and systems for medical, industrial and security applications.

Varex Imaging Corporation entered into an Agreement and Plan of Merger with Teledyne Technologies Incorporated and its subsidiary Detect Merger Sub, Inc. on August 10, 2026. Under the merger agreement, each outstanding share of Varex common stock will be converted into the right to receive $18.90 in cash per share at the effective time of the merger. The company's stockholders must approve the merger agreement, and the transaction is expected to close in early 2027, subject to customary closing conditions including regulatory approvals and the absence of a material adverse effect. The merger is not subject to any financing condition, with Parent expecting to utilize borrowings under its existing credit facility to finance the transaction.

## Terms
- Counterparty: Teledyne Technologies Incorporated · Consideration: cash · Price/share: $18.9

## Key dates
- Announced 2026-08-10 · Expiry 2027-08-10 · Expected close 2027-01-31

## Timeline
- 2026-08-10 · 8-K (0001104659-26-093349): 8-K - Varex Imaging Corp — *Varex Imaging Corporation designs, manufactures, distributes and services X-ray imaging components and systems for medical, industrial and security applications.* Varex Imaging Corporation entered into an Agreement and Plan of Merger with Teledyne Technologies Incorporated and its subsidiary Detect Merger Sub, Inc. on August 10, 2026. Under the merger agreement, each outstanding share of Varex common stock will be converted into the right to receive $18.90 in cash per share at the effective time of the merger. The company's stockholders must approve the merger agreement, and the transaction is expected to close in early 2027, subject to customary closing conditions including regulatory approvals and the absence of a material adverse effect. The merger is not subject to any financing condition, with Parent expecting to utilize borrowings under its existing credit facility to finance the transaction.
  https://www.sec.gov/Archives/edgar/data/1681622/0001104659-26-093349.txt

## Citations
- 0001104659-26-093349 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926093349